Dr Chinmaya Kumar Pani

Experience: 10 yrs+

I am a doctor - it’s a profession that may be considered a special mission, a devotion. It calls for involvement, respect and willingness to help all other people.

Qualification

M.B.B.S,M.D. (Peadiatrics): Senior Resident(Medical Oncology): AIIMS,New Delhi D.M. (Medical Oncology):JIPMER, PONDICHERRY ECMO 2015-2020, Associate Prof (Medical Oncology ) IMS &SH,BBSR

Language

English, हिंदी, ଓଡ଼ିଆ, தமிழ்

Registration No

OCMR-15262 /04 ; DMC-43847

Experience

10 years +

Location

Apollo Hospitals Bhubaneshwar

Apollo Hospitals, 251, Old Sainik School Road, Unit-15, Orissa, Bhubaneswar - 751 005 Ph:0674 - 6661016/1066

Timing MON- SAT (10:00 AM-05:00 PM)

Get Direction

Work Experience

Awards and Achievements

1.2nd prize in ACUTE LEUKEMIA QUIZ: In international Leukemia meet, 2014, Cancer Institude Chennai

2.1st prize in physiology in ‘‘NanditaBehera Memorial Award-2000’’

3.1st prize in oral paper presentation in east zone peadiatric conference Imphal-2008 “Pattern of peadiatricpoisoing in Orissa ,a single centre experience.”

Research and Publications

Major publication:

1. Chinmaya Kumar Pani, SaritaMohapatra, Jyotish Chandra Samantaray, Sameer BakhshiVisceral leishmaniasis as a cause of persistent fever in pediatric Hodgkin lymphoma.

2.Pani CK,Dubashi.B,Cyriac.SL,Dhanraj.KM,Verma SK,Sistla SC,et al.First Line Treatment for Advanced Gastroesophageal Cancer:Capecitabine Plus Oxaliplatin(CAPOX) versus Epirubicin ,Oxaliplatin Plus Capecitabine (EOX).Austin J Cancer Clin Res.2017;4(1):1073

3.SmitaKayal, ChinmayakumarPani, DubashiBiswajit, SurendrakumarVerma, Sarath Chandra Sistla,Sunu Lazar Cyriac; Comparison of efficacy and safety of capecitabine and oxaliplatin (CAPOX) with epirubicin, oxaliplatinpluscapecitabine (EOX) as first line treatment for advanced gastric cancer (AGC), a randomized clinicalstudy; J ClinOncol 33, 2015 (suppl; abstr e15026)

Oral paper presenatation:

1.Oral paper presenatation ;ICC 2013:Cytogenetics profile in Acute Leukemia a single Centre data

2.Oral paper presenatation :ISMPO 2014; Hypersensitivity reaction to Cetuximab , a rare known entity

3.East zone peadiatric conference Imphal-2008 “Pattern of peadiatric poisoing in Orissa ,a single centre experience.”

Professional Memberships

Certifications : Certificate course in Good clinical practice research training 2014

European society of medical oncology 2015

Memberships : IMA,IAP,ASCO,ESMO,ISMPO,ICON

Timing MON- SAT (10:00 AM-05:00 PM)

Book Appointment